|
|
Profile
|
Delegates :
Kazuhiko Yamamoto |
|
Incorporated :
February 21 , 2017 |
Paid in Capital :
3847 Million yen Incl. capital reserves |
Employees :
40 人 |
Address :
CLIK4F, 6-3-7 Minatojima-Minamimachi Chuo-ku, Kobe HYOGO
〒650-0047
|
TEL/FAX :
/ |
URL：
https://www.synplogen.com/en/ |
Attachment :
|
Mission/Background :
Synplogen Co., Ltd. is a synthetic biology startup established in February 2017, originating from Kobe University’s Graduate School of Science, Technology and Innovation. Using our proprietary DNA synthesis technologies "OGAB" and "Combinatorial-OGAB", we provide DNA synthesis and DNA library construction services, and as a biofoundry specializing in gene therapy,“Gene Therapy Biofoundry”, we also provide design, development and analysis services for gene therapy products such as viral vectors and mRNA. |
|
Technology & Business
|
"OGAB" can be used to synthesize DNA of various lengths over 100 kbp, as well as complex DNA syntheses with features such as high/low GC content and repeat sequences. We also design and construct large and diverse DNA libraries tailored to our clients’ needs using "Combinatorial-OGAB".
We provide "Gene Therapy Biofoundry Services" related to commercializing research for gene therapy products (Chemistry, Manufacturing and Control: CMC). In addition, through collaborations with domestic and overseas development partner companies capable of GMP-compliant manufacturing, we have established an integrated development and manufacturing value chain that will contribute to early entry into clinical trials and early commercialization of innovative gene therapy products.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Custom DNA Synthesis Services
|
Launched
|
|
|
Gene Therapy Biofoundry Services
|
Launched
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|